Resurrect Bio is a London-based plant biotech startup founded in 2021, with a mission to enhance the immune systems of crop species. The company focuses on addressing the issue of lost immune resistance genes in crop species that were inadvertently bred out over generations. Their efforts come at a crucial time as modern monocultures face evolving threats from pests and pathogens due to static evolution. The impact of climate change further exacerbates the spread of plant diseases to new locations, expanding the spectrum of diseases that farmers have to combat.
The last funding round on 16 May 2023 secured a significant £1.61M investment from prominent investors, including AgFunder, UK Innovation & Science Seed Fund, Future Planet Capital, SynBioVen, and Shake climate. With a focus on biotechnology and their commitment to revolutionizing crop disease resistance, Resurrect Bio is positioned as a promising player in the agritech industry. Their innovative approach to addressing critical challenges in agriculture demonstrates their potential to make a substantial impact in the market while contributing to sustainable food production.